摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-(tert-Butoxycarbonylamino)-5-benzyloxypentanoic acid | 148529-07-1

中文名称
——
中文别名
——
英文名称
(S)-2-(tert-Butoxycarbonylamino)-5-benzyloxypentanoic acid
英文别名
(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-phenylmethoxypentanoic acid
(S)-2-(tert-Butoxycarbonylamino)-5-benzyloxypentanoic acid化学式
CAS
148529-07-1
化学式
C17H25NO5
mdl
——
分子量
323.389
InChiKey
SLSGDJMDQHCUBN-AWEZNQCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    487.3±45.0 °C(Predicted)
  • 密度:
    1.136±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    23
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    84.9
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-2-(tert-Butoxycarbonylamino)-5-benzyloxypentanoic acidpalladium dihydroxide四(三苯基膦)钯 吗啉咪唑盐酸 、 lithium hydroxide 、 氰基磷酸二乙酯五氟苯基二苯基磷酸酯氢气溶剂黄146三乙胺N,N-二异丙基乙胺 作用下, 以 四氢呋喃1,4-二氧六环二氯甲烷乙酸乙酯N,N-二甲基甲酰胺 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 103.5h, 生成 dibenzyl [(2S)-2-[tert-butyl(dimethyl)silyl]oxy-3-[[(3S,6S,9S,12S,15S,18S,19R)-9,15-dibenzyl-3-[(2S)-butan-2-yl]-6-[[4-[tert-butyl(dimethyl)silyl]oxyphenyl]methyl]-12-(3-hydroxypropyl)-7,19-dimethyl-2,5,8,11,14,17-hexaoxo-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]amino]-3-oxopropyl] phosphate
    参考文献:
    名称:
    Synthetic studies of the cyclic depsipeptides bearing the 3-amino-6-hydroxy-2-piperidone (Ahp) unit. Total synthesis of the proposed structure of micropeptin T-20
    摘要:
    The first total synthesis of a cyclic depsipeptide possessing the 3-amino-6-hydroxy-2-piperidone (Ahp) unit was successfully IN achieved in a convergent manner by the oxidative construction of the Ahp unit at the later stage of the synthesis. This synthetic work provides data indicating that the structure of the target Ahp-depsipeptide, micropeptin T-20. should be re-examined. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2004.12.009
  • 作为产物:
    描述:
    (S)-2-tert-Butoxycarbonylamino-5-ethoxycarbonyloxy-5-oxo-pentanoic acid benzyl ester 在 lithium hydroxide 、 sodium tetrahydroborate 、 silver(l) oxide 作用下, 以 四氢呋喃乙醚 为溶剂, 生成 (S)-2-(tert-Butoxycarbonylamino)-5-benzyloxypentanoic acid
    参考文献:
    名称:
    Synthetic studies of micropeptin T-20, a novel 3-amino-6-hydroxy-2-piperidone (Ahp)-containing cyclic depsipeptide
    摘要:
    The synthetic studies of micropeptin T-20 including the late installation of the Ahp (3 -amino- 6-hydroxy-2-piperidone) residue through oxidation and cyclization of a homoserine to the requisite hemiaminal are described. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(01)01136-4
点击查看最新优质反应信息

文献信息

  • Chemical Compounds
    申请人:Pfizer Limited
    公开号:US20130274243A1
    公开(公告)日:2013-10-17
    The invention relates to benzimidazole and imidazopyridine derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new Na v 1.8 modulators of formula (I) or pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , X and Y are as defined in the description. Na v 1.8 modulators are potentially useful in the treatment of a wide range of disorders, particularly pain.
    本发明涉及苯并咪唑和咪唑吡啶衍生物,它们在医学上的使用、含有它们的组合物、制备它们的过程以及用于这种过程的中间体。更具体地,本发明涉及公式(I)或其药学上可接受的盐的新型Nav1.8调节剂,其中R1、R2、R3、R4、R5、R6、R7、X和Y如描述中所定义。Nav1.8调节剂在治疗广泛的疾病,尤其是疼痛方面具有潜在的用途。
  • Chemical compounds
    申请人:Pfizer Limited
    公开号:US08927587B2
    公开(公告)日:2015-01-06
    The invention relates to benzimidazole and imidazopyridine derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new Nav1.8 modulators of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7. X and Y are as defined in the description. Nav1.8 modulators are potentially useful in the treatment of a wide range of disorders, particularly pain.
    本发明涉及苯并咪唑和咪唑吡啶衍生物,其在医学上的应用,含有它们的组合物,其制备过程以及用于这种过程中的中间体。更具体地,本发明涉及公式(I)的新型Nav1.8调节剂或其药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,R7,X和Y如描述中所定义。Nav1.8调节剂在治疗广泛的疾病,特别是疼痛方面具有潜在的用途。
  • Inhibitors of nitric oxide biosynthesis
    申请人:MERRELL PHARMACEUTICALS INC.
    公开号:EP0446699A1
    公开(公告)日:1991-09-18
    The present invention is directed to a new class of compound which are useful as inhibitors of the biosynthesis of nitric oxide.
    本发明涉及一类可用作一氧化氮生物合成抑制剂的新型化合物。
  • Synthesis of an analogue of the substance P C-terminal hexapeptide with modification at the glutaminyl and methioninyl residues and increased activity in NK-2 receptor type: Structure-activity relationships
    作者:A Manolopoulou、C Poulos、T Tsegenidis
    DOI:10.1016/0223-5234(92)90027-x
    日期:1992.12
    Analogues of [Orn6]-Sp6-11 have been synthesized in which the Met11 residue is replaced by Hse(CH3), Hse(Bzl), Nva(5-OCH3), Nva(5-OBzl) and Abu. These analogues were tested in 3 in vitro preparations representative of NK-1, NK-2 and NK-3 receptor types. The Hse(Bzl) analogue is 16.6-fold more potent than the parent hexapeptide at the NK-2 receptor and 2.4-fold more potent at the NK-3 receptor. The Nva(5-OCH3) analogues howed weak antagonist activity in NK-2 and NK-3 receptor types, being a full agonist at NK-1. It is concluded from structure-activity correlations that the role of Met11 side chain in substance P is associated with activity and/or efficacy, as appropriate modifications in the side chain may result either in agonists with increased activity compared to the parent hexapeptide or selective agonists or may induce antagonism.
  • Synthetic studies of micropeptin T-20, a novel 3-amino-6-hydroxy-2-piperidone (Ahp)-containing cyclic depsipeptide
    作者:Fumiaki Yokokawa、Akiko Inaizumi、Takayuki Shioiri
    DOI:10.1016/s0040-4039(01)01136-4
    日期:2001.8
    The synthetic studies of micropeptin T-20 including the late installation of the Ahp (3 -amino- 6-hydroxy-2-piperidone) residue through oxidation and cyclization of a homoserine to the requisite hemiaminal are described. (C) 2001 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物